Caxton Associates (New York)’s Itron ITRI Stock Holding History
Bought
Maintained
Sold
Other funds holding ITRI
ACB
Caxton Associates (New York)'s ITRI Position: Q4 2021 in Review
Caxton Associates (New York) sold out of Itron (ITRI) in Q4 2021, closing a stake of 7,730 shares — an estimated $585K sold.
Caxton Associates (New York) first reported a position in ITRI in Q4 2019 and held it in 4 quarters. The position peaked at $5.44M in Q2 2020. 261 funds tracked by Wall St. Rank hold ITRI as of Q4 2021.
- Caxton Associates (New York) reported no remaining Itron position as of Q4 2021 after selling out during the quarter.
- Caxton Associates (New York) sold 7,730 Itron shares in Q4 2021, an estimated $585K.
- Caxton Associates (New York) first reported a position in Itron in Q4 2019 and held it in 4 quarters.
- Caxton Associates (New York)'s Itron position peaked at $5.44M in Q2 2020.
- 261 funds tracked by Wall St. Rank held Itron as of Q4 2021.
Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.